FDA's plan to boost cheaper copycat drugs could stall at the patent office

The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
BioSpace

FDA Unwraps ‘Plausible Mechanism Pathway’ for Personalized Therapies

The plausible mechanism pathway "could accelerate gene therapy/editing development," analysts at William Blair said Thursday, ...
CURE

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...
MPR

FDA Approves Poherdy, the First Interchangeable Biosimilar to Perjeta

Poherdy can be dispensed as a substitute for Perjeta without requiring a prescription change from a health care provider.
JD Supra

FDA issues letter to industry on recall communications for infant and baby foods

On July 9, 2025, the U.S. Food and Drug Administration (FDA) issued a letter from Commissioner for Human Foods Martin Makary and Deputy Commissioner for Human Foods Kyle Diamantas to industry members ...
Hosted on MSN

Gov. Tim Walz to maintain COVID-19 vaccine access in Minnesota despite new FDA guidelines

Minnesota Gov. Tim Walz signed an executive order Sept. 8 to safeguard vaccine accessibility, nearly two weeks after the Food and Drug Administration approved the latest round of COVID-19 vaccines.
Global News - Inquirer.net on MSN

FDA issues Public Health Warning on counterfeit ‘Keytruda’ (100 mg/4 mL) injection

The Food and Drug Administration (FDA) advises the public against the purchase and use of the counterfeit version of the ...